TY - JOUR AU - Jarlborg, Matthias AU - Courvoisier, Delphine S. AU - Lamacchia, CĂ©line AU - Martinez Prat, Laura AU - Mahler, Michael AU - Bentow, Chelsea AU - Finckh, Axel AU - Gabay, Cem AU - Nissen, Michael J. AU - on behalf of the physicians of the Swiss Clinical Quality Management (SCQM) registry PY - 2020 DA - 2020/05/06 TI - Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis JO - Arthritis Research & Therapy SP - 105 VL - 22 IS - 1 AB - Calprotectin (S100A8/S100A9 protein) is known as a damage-associated molecular pattern (DAMP) protein and reflects mainly neutrophil activation. Serum calprotectin levels might be a good alternative to acute-phase protein as a biomarker in inflammatory rheumatic diseases. The aim of this study is to investigate the association of serum calprotectin with disease activity and severity in rheumatoid arthritis (RA), axial spondyloarthritis (axSpA), and psoriatic arthritis (PsA). SN - 1478-6362 UR - https://doi.org/10.1186/s13075-020-02190-3 DO - 10.1186/s13075-020-02190-3 ID - Jarlborg2020 ER -